phenyl acetate has been researched along with Nephrosis, Lipoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Kawada, M; Mizuno, H; Oshima, Y; Sawa, N; Sekine, A; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y; Yamanouchi, M | 1 |
| MASSONNAT, J; NAHON, C; PORTIER, A; SABON, F | 1 |
2 other study(ies) available for phenyl acetate and Nephrosis, Lipoid
| Article | Year |
|---|---|
Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders.
Topics: Acetates; Adrenal Cortex Hormones; Adult; Aged; Cetirizine; Cyclopropanes; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Immunosuppressive Agents; Leukotriene Antagonists; Male; Middle Aged; Nephrosis, Lipoid; Prednisolone; Propensity Score; Quinolines; Retrospective Studies; Sulfides; Treatment Outcome; Young Adult | 2020 |
[The urinary elimination of guanidine-acetic acid (glycocyamine) during lipoid nephrosis and nephrotic syndromes].
Topics: Acetates; Acetic Acid; Glycine; Guanidine; Guanidines; Nephrosis; Nephrosis, Lipoid; Nephrotic Syndrome | 1951 |